BAB V KESIMPULAN DAN SARAN
B. Saran
1. Pihak Rumah Sakit
Rekam medik pasien sebaiknya ditulis dengan jelas, lengkap, dan memuat catatan dari beberapa tenaga kesehatan lain yang
dibutuhkan selain sebagai kelengkapan administrasi juga memudahkan dalam pemantauan kondisi pasien.
2. Peneliti Selanjutnya
Peneliti selanjutnya diharapkan melakukan identifikasi DRPs secara prospektif melalui wawancara pasien, dokter, perawat maupun farmasis untuk mendapatkan data yang dibutuhkan secara lengkap sehingga dapat memudahkan identifikasi DRPs secara keseluruhan.
xv
DAFTAR PUSTAKA
Acton, A (ed.). 2013. Congestive Heart Failure: New Insights for the Healthcare Professional. Scholarly Editions.
Adler, E.D., Goldfinger, J.Z., Kalman, J., Park, M.E., Meier, D.E., 2009, Palliative Care in the Treatment of Advanced Heart Failure, American Heart Association, 120, 2597-2606 [pdf]. Diakses pada tanggal 25 Mei 2016, dari http://www.circ.ahajournals.org/
Adusumilli, P.K & Adepu, R., 2014, Drug Related Problems : an overview of various classifications system, Asian J Pharm Clin Res, 07, 0974-2441.
Diakses 09 Juni 2015, dari
http://innovareacademics.in/journals/index.php/ajpcr/article
Aldredge, B.K., Corelli, R.L., Ernst, M.E., Guglielmo, B.J., et al., 2013, Koda-Kimble &Youngs : Applied TheurapeuticsThe Clinical Use of Drugs (10th eds). Philadelphia: PA 19103 USA.
Alpha Diagnostic International, 2011, Product Data Sheet: Nystatin, Woodlake Center, USA
Alvarez, A.M & Mukherjee, D., 2011, Liver Abnormalities in Cardiac Diseases and Heart Failure, International Journal of Angiology, 03-20 [pdf]. Diakses
pada tanggal 13 Juni 2016, dari
www.ncbi.nlm.nih.gov/pmc/articles/PMC3331650/pdf/ija20135.pdf
Anticoagulation Europe, 2012, Warfarin Interactions, 1090250 [pdf], UK.Diakses
pada tanggal 26 Mei 2016, dari
http://www.anticoagulationeurope.org/files/files/Some%20of%20the%20mos t%20common%20interactions%20with%20warfarin%20.pdf.
Baillargeon, J., Holmes, H.M., Lin, Y., Raji, A.M., Sharma, G., et al, 2012, Concurrent Use of Warfararin and Antibiotics and the Risk of Bleeding in Older Adults, The American Journal of Medicine, 02-125, 183-189 [pdf].
Diakses pada tanggal 26 Mei 2016, dari
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3712345/pdf/nihms322513.pd f
Bangalore, S., Kumar, S., Messerli, F.H., 2010, Angiotensin-Converting Enzyme Inhibitor Associated Cough: Deceptive Information from the Physicians Desk Abstract, The American Journal of Medicine, 11-123, 1016-1030. Diakses pada tanggal 08 Mei 2016, dari http://www.amjmed.com/article/S0002-9343%2810%2900571-1/abstract
Baxter, Karen.BSc, MSc, MRPharmS (ed.). 2008. Stockley’s Drug Interactions (8th eds) :A source book of interactions, their mechanisms, clinicalimportance and management. Great Britain: Pharmaceutical Press of Great Britain.
Berkowitz, A., 2013, Patofisiologi Klinik., 22, Penerbit : Binarupa aksara.
Bissessor , N & White, H., 2007, Valsartan in Treatment of Heart Failure or Left Ventricular Dysfunction After Myocardial Infarction, Vascular Health Risk and Management, 04-03, 425-430. Diakses pada tanggal 25 Mei 2016 dari http://www. ncbi.nlm.nih.gov/pmc/articles/PMC2291334/
Bueno, H., Ross, J., Wang, Y., et al, 2010, Trends in Length of Stay and Short-term Outcomes Among Medicare Patient Hospitalized for Heart Failure,
xvi
1993-2006, JAMA, 21, 303 [pdf]. Diakses pada tanggal 07 Mei 2016, dari http://www.archopht.jamanetwork.com/
Bui, A., Tamara, B., Horwich., Fonarow, G., 2011, Epidemiology and risk profile Heart Failure, 8, 30-41, 10.1038. Diakses pada tanggal 05 Mei 2016, dari http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3033496/
Ceconi, C., Francolini, G., Olivares, A., Comini, L., Bachetti, T., Ferrari, R., 2007, Angiotensin-Converting Enzyme (ACE) Inhibitors have Different Selectivity for Bradykinin Binding Sites of Human Somatic ACE Abstract, European Journal of Pharmacology, 01-03-577, 01-06. Diakses pada tanggal 25 April 2016, dari
Choueiri, T.K., Maver, E.L., Je, Y., Rosenberg, J.E., Nguyen, P.L., Azzi, G.R., et al, 2011, Congestive Heart Failure Risk in Patients with Breast Cancer Treated with Bevacizumab Abstract, Clinical Journal of Oncology, 08-632.
Diakses pada tanggal 09 Mei 2016, dari
http://jco.ascopubs.org/content/29/6/632.long
Ciccone C., 2014, e-Study Guide for: Pharmacology in Rehabilitation 4th Ed., Cram 101 Textbook Reviews, 9781467287920.
Curtis, L.H., Whellan, D.J., Hammili, B.G., Hermandez, A.F., Anstrom, K.J., Shea, A.M., et al, 2008, Incidence and Prevalence of Heart Failure in Elderly Persons 1994-2003 Abstract, Arch Intern Med, 04-168, 418-24. Diakses pada tanggal 26 Mei 2016, dari http://www.ncbi.nlm.nih.gov/pubmed/18299498 Dasari, S dan Bernard, P.T., 2014, Cisplatin in Cancer Therapy: Molecular
Mechanisms of Action, The European Journal of Pharmacology, 364-378
[pdf]. Diakses pada tanggal 13 Mei 2016, dari
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4146684/pdf/nihms-615599.pdf.
Dicpinigaitis, P., 2006, Angiotensin-Converting Enzyme Inhibitor-Induced Cough, ACCP Evidence-Based Clinical Practice Guidelines, 129, 169S-173S [pdf].
Diakses pada tanggal 24 April 2016, dari
http://www.journal.publications.chestnet.org/
Dinas Kesehatan Daerah Istimewa Yogyakarta.2013.Profil Kesehatan Daerah Istimewa Yogyakarta.Yogyakarta.
Endah, N.S., 2014, Identifikasi Drug Related Problems pada Penatalaksanaan pasien Congestive Heart Failure di Instalasi Rawat Inap Rumah Sakit Umum PKU Muhammadiyah Bantul Yogyakarta, Skripsi, Program Studi Farmasi Fakultas Kedokteran dan Ilmu Kesehatan Universitas Muhammadiyah Yogyakarta, Yogyakarta.
European Medicine Agency, 2010. Science Medicine
Health.CPMP/EWP/560/95/Rev.1
Figueroa, S Michael., MD & Peters, I Jay., MD FAARC.2006. Congestive Heart Failure: Diagnosis, Pathophysiology, Therapy, and Implications for Respiratory Care. Daedalus Enterprises, Vol 51 No 4
Ford, I., Robertson, M., Komadja, M., Bohm, M., Borer, J.S., Tavazzi, L., Swedberg, K., 2015, Top ten risk factors for morbidity and mortality in patients with chronicsystolic heart failure and elevated heart rate: The SHIFT Risk Model, IJC, 184, 163-169
xvii
Francis, S., Cheng, S., Arteaga, C.L., Moslehi, J., 2014, Heart Failure and Breast Cancer Therapies: Moving Towards Personalized Risk Assesment, Journal of the American Heart Association, 10.1161 [pdf]. Diakses pada tanggal 08 Mei 2016, dari http://www.jaha.ahajournals.org/
Friedrich, C.Lufth., 2013, Aminoglycoside Interactions with Other Drugs, Clinical and Toxicologic Implications, 135-138 cit Porter, G.A., 2013, Nephrotoxic Mechanisms of Drugs and Environmental Toxins (Eds). Springer Science+Business Media, LLC. Oregon.
Gavronski, M., Hartikainen, S., Zharkovsky, A., 2012, Analysis of Potential Interactions Between Warfarin and Prescriptions in Estonian Outpatients Aged 50 Years or More, Pharmacy Practice, 1886-3655 [pdf]. Diakses pada tanggal 26 Mei 2016, dari http://www.pharmacypractice.org
Gheorghiade, M., Sopko, G., Luca, L.D., Velazquez, E.J., Parker, J.D., et al, 2006, Navigating the Crossroads of Coronary Artery Disease and Heart Failure, Circulation AHA, 106.623199 [pdf]. Diakses pada tanggal 07 Mei 2016, dari http://www.circ.ahajournals.org/content/114/11/1202.full
Golias, Ch., Charalabopoulos, A., Stagikas, D., Charalabopoulos, K., Batistatou, A., 2007, The Kinin System-Bradykinin: Biological Effects and Clinical Implications. Multiple Role of the Kinin System-Bradykinin, Hippokratia, 03,
124-128 [pdf]. Diakses pada tanggal 25 April 2016, dari
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2658795/pdf/hippokratia-11-124.pdf
Hadiatussalamah, 2013, Identifikasi Drug Related Problems pada pasien dengan Diagnosa Congestive Heart Failure di Instalasi Rawat Inap Rumah Sakit Umum Dr. Mohammad Hoesin Palembang, Skripsi, Fakultas Farmasi Universitas Gadjah Mada, Yogyakarta.
Hall, M.J., Levant, S., DeFranches, C.J., 2012, Hospitalization for Congestive Heart Failure : United States, 2000-2010, NCHS data brief, 108 [pdf].
Diakses pada tanggal 16 Mei 2015, dari
http://www.cdc.gov/nchs/data/databriefs/db108.pdf
Hunt, S.A., Abraham, W.T., Chin, M.H., Feldman, A.M., Francis, G.S., Ganiats, T.G., et al. 2009. 2009 Focused Updated Incorporated into the ACC/AHA 2005 Guidelines for the Diagnosis and Management of Heart Failure in Adults, JACC, 53, 0735-1097.
Kehat, I.Molkentin, J.D., 2010, Molecular Pathways Underlying Cardiac Remodeling During Pathophysiological Stimulation, AHA Circulation, 122, 2727-2735. Diakses 25 Mei 2015, dari http://circ.ahajournals.org/
Kementerian Kesehatan Republik Indonesia, 2014, Pusat Data dan Informasi : Situasi Kesehatan Jantung [pdf]. Diakses pada tanggal 26 Mei 2016, dari http://www.depkes.go.id/download.php?file=download/pusdatin/infodatin/inf odatin-jantung.pdf.
Krishnan, E., 2009, Hyperuricemia and Incident Heart Failure, Circ Heart Fail, 02, 556-562 [pdf]. Diakses pada tanggal 25 Mei 2016, dari http://www.circheartfailure.ahajournals.org/
Koshman, S.L., Charrois, T.L., Simpson, S.H., McAlister, F.A., Tsuyuki, R.T., 2008, Pharmacist Care of Patients with Heart Failure : A Systematic Review
xviii
of Randomized Trials, American Medical Association, 07-168 [pdf]. Diakses pada tanggal 13 Juni 2016, dari http://www.archpsyc.jamanetwork.com/ Lahner, E., Annibale, B., Fave, D.G., 2009, Systematic Review: Impaired Drug
Absorption Related to the Co-Administration of Antisecretory Therapy Abstract, Alimentary Pharmacology and Therapeutics, 12-29, 1219-1229.
Diakses pada tanggal 25 Mei 2016, dari
http://onlinelibrary.wiley.com/doi/10.1111/j.13652036.2009.03993.x/abstract Larina, V.N., Bla, B., Brodskii, M.S., 2011, Hyperuricemia in Chronic Heart
Failure Abstract, Kardiologia, 03-51, 68-73. Diakses pada tanggal 25 Mei 2016, darihttp://www.ncbi.nlm.nih.gov/pubmed/21627617
Magro, L., Conforti, A., Delzotti, F., Leone, R., Lorio, M.L., Meneghelli, I., et al., 2007, Identification of Severe Potential Drug-drug Interactions using an Italian General-Practitioner database, Eur J Clin Pharmacol, Springer Verlag.
Mann, D.L., 2012, Braunwalds Heart Disease a textbook of Cardiovascular Medicine (9theds), 487-489
Maron, B.A & Leopold, J.A., 2010, Aldosterone Receptor Antagonists Effective but Often Forgotten, American Heart Association, 121, 934-939 [pdf]. Diakses pada tanggal 25 Mei 2016, dari http://www.circ.ahajournals.org/ McMurray, JV., Adamopoulos, S., Anker, D.S., Auricchio, A., Bohm, M.,
Dickstein, K., et al.European Society of Cardiology Guidelines, 2012.Diagnosis and Treatment of Acute and Chronic Heart Failure.EHJ, 33,
1787–1847. Diakses 11 Mei 2015, dari http://www.escardio.org/Guidelines-&-Education/Clinical-Practice Guidelines/Acute-and-Chronic-Heart-Failure McQuaid, K.R., Laine, L., 2006, Systematic Review and Meta-analysis of Adverse
Events of Low-dose Aspirin and Clopidogrel in Randomized Controlled Trials, The American Journal of Medicine, 119, 624-638 [pdf]. Diakses pada
tanggal 26 Mei 2016, dari
http://www.amjmed.com/article/S0002-9343(05)01043-0/pdf
Mehta, P.A. & Cowie, M.R., 2006, Gender and Heart Failure : a population perspective, 92, 10.1136. Diakses pada tanggal 05 Mei 2016, dari http://www.ncbi.nlm.nih.gov/pmc/articles/PMC1860739/
National Heart Lung and Blood Institute, 2016, What is Cardiogenic Shock.
Diakses pada tanggal 26 Mei 2016, dari
http://www.nhlbi.nih.gov/health/health-topics/topics/shock
National Institute for Health and Care Excellence, 2014, Gastro-oesophageal Reflux Disease and Dyspepsia in Adults: Investigation and Management Clinical Guideline [pdf]. Diakses pada tanggal 26 April 2016, dari http://www.nice.org.uk/guidance/cg184
National Institute for Health and Care Excellence. 2010. Chronic Heart Failure : Management of Chronic Heart failure in Adults in Primary and Secondary Care.
Oren, R.M., 2005, Hyponatremia in Congestive Heart failure Abstract, The American Journal of Cardiology, 09-95, 02-07. Diakses pada tanggal 28 April 2016, dari http://www.ajconline.org/article/S0002-9149%2805%2900353-X/abstract
xix
Pacher, P., Nivorozhkin, A., Szabo, C., 2006, Therapeutic Effects of Xanthine Oxidase Inhibitors: Renaissance Half a Century after the Discovery of Allopurinol, Pharmacological Review, 01-58, 87-114 [pdf]. Diakses pada
tanggal 29 April 2016, dari
http://www.pharmrev.aspetjournals.org/content/58/1/87.full.pdf+html
Parker, R.B., Patterson, H.J., Johnson, J.A., 2008, Heart Failure dalam Dipiro, J.T., Talbert, L.R., Yee, C.G., Matzke, R.G., Wells, B.G., Posey, M.L., Pharmacotherapy A Pathophysiologic Approach 7th Ed, The McGraw-Hill Companies, New York.
Pharmaceutical Care Network Europe Foundation, 2006.PCNE Classification for Drug related problems V5.01.[pdf]. Diakses 16 Mei 2015, dari www.pcne.org/working-groups/2/drug-related-problems
Porth, M.C., 2007, Pathophysiology Concepts of Altered Health States., Chap 20 : 429.
Rohilla, A. & Yadav, S., 2013, Adverse Drug Reactions : An overview, IJPR, 3, 2277-3312. Diakses pada tanggal 05 Juni 2015, dari http://ssjournals.com Santoso, I., Efi, A.R., Rahmatillah, D.R., 2015, Case Report : Drug Related
Problem (DRP) Associated with the Treatment of Congestive Heart Failure (CHF) in PGI Cikini Hospital, International Journal of Pharmacy Teaching & Practices (IJPTP), 01-06, 1609-2092 [pdf]. Diakses pada tanggal 13 Juni 2016, dari
http://www.iomcworld.com/ijptp/files/VOL%2006,%20ISSUE%2001,%20S UPPLEMENT%20I,%20MARCH%202015.pdf#page=325
Sharma, S., Chhetri, H.P., Alam, K., 2014, A Study of Potential Drug-drug Interactions Among Hospitalized Cardiac Patients in a Teaching Hospital in Western Nepal, Indian Journal of Pharmacology, 02-46, 152-156. Diakses
pada tanggal 26 Mei 2015, dari
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3987181/
Shin, J.M., Kim, N., 2013, Pharmacokinetics and Pharmacodynamics of the Proton Pump Inhibitors, Journal of Neurogastroenterology and Motility,
01-19, 105056 [pdf]. Diakses pada tanggal 26 Mei 2016, dari
http://www.jnmjournal.org
Srikanth, B.A., Berhanie, A., Tigistu, H., Abraham, Y., Getachew, Y., Khan, M.T., Unakal, C., 2014, Prevalence of Potential Drug-drug Interactions among Internal Medicine Ward in University of Gondar Teaching Hospital, APJTB, 4, S204-S208. Diakses pada 04 Juni 2015, dari http://apjtb.com Steadman, E., Raisch, D.W., Bennett, C.L., Esterly, J.S., Becker, T., Postelnick,
M., et al, 2010, Evaluation of a Potential Clinical Interaction Between Ceftriaxone and Calcium, American Society for Microbiology, 04-54,
101128 [pdf]. Diakses pada tanggal 26 Mei 2016, dari
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC2849391/pdf/1111-09.pdf Tatro, D.S., 2010, Drug Interaction Facts TM, Wolters Kluwer Health, USA. Thanassoulis, G., Brophy, J.M., Richard, H., Pilote, L., 2010, Gout, Allopurinol
Use, and Heart Failure Outcomes, JAMA, 15-170 [pdf]. Diakses pada tanggal 26 Mei 2016, dari http://www.archneur.jamanetwork.com/
xx
Verbrugge, F.H., Steels, P., Grieten, L., Nijst, P., Tang, W., Mullens, W., 2015, Hyponatremia in Acute Decompensated Heart Failure, Journal of the American College of Cardiology, 05-65, 0715-1097 [pdf]. Diakses pada tanggal 28 April 2016, darihttp://www.content.onlinejacc.org/
Wells, B.G., Dipiro, J.T., Schwinghammer, T.L., & Dipiro, C.V., 2015, Pharmacotherapy Handbook (9th ed) : Heart Failure, 75-81, MC Graw Hill Education.
Wong, C.Y., Chaudhry, S.I., Desai, M.M., Krumholz, H.M., 2011, Trends in Comorbidity, Disability, and Polypharmacy in Heart Failure, The American Journal of Medicine, 02-142, 136-143 [pdf]. Diakses pada tanggal 26 April 2016, dari http://www.ncbi.nlm.nih.gov/pmc/articles/PMC3237399/
World Health Organization. 2006. Developing Pharmacy Practice, 7
Xia, Li, 2013, Cohlear Cell Death Induced Via Cisplatin or Gentamycin in Combination with Furosemide in Rodents, Clinical Journal of Toxicology, 03-04, 2161-0495 [pdf]. Diakses pada tanggal 26 Mei 2016, dari http://www.omicsonline.org/pdfdownload.php?download=cochlear-cell- death-induced-via-cisplatin-or-gentamycin-in-combination-with-furosemide-in-rodents-2161-0495.1000-166.pdf
Yancy., et al, 2013. Management of Heart Failure: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines. Diakses 11 Mei 2015, dari http://circ.ahajournals.org
xxi LAMPIRAN Lampiran 1.Form Pengambilan Data
I. IDENTITAS PASIEN Pasien : Umur : TB : BB : No CM : Ruang : Tgl MRS : Tgl KRS : II. PERINCIAN PASIEN Keluhan utama : Diagnosis : III. RIWAYAT Riwayat penyakit : Riwayat keluarga/sosial :
xxii
Parameter Nilai
Rujukan
Uraian